Heron Therapeutics Inc (NASDAQ:HRTX)

14.22
Delayed Data
As of Mar 27
 +0.23 / +1.64%
Today’s Change
6.51
Today|||52-Week Range
16.49
+41.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization114.0K125.0K150.0K--
 
 
 
 
 
Operating ExpensesGross Income-114.0K-125.0K-150.0K0.00
 
 
 
 
General Expenses17.2M18.7M18.8M19.5M
 
 
 
 
 
Research And Development11.8M14.4M14.7M14.2M
 
 
 
 
 
Total Operating Expenses17.3M18.8M19.0M19.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.3M-18.8M-19.0M-19.5M
 
 
 
 
 
Interest Expense On Debt216.0K220.0K241.0K--
 
 
 
 
Other Expenses0.000.000.00-1.1M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.5M-19.0M-19.2M-20.6M
 
 
 
 
 
Net Income-17.5M-19.0M-19.2M-20.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.7M24.3M29.0M29.2M
 
 
 
 
 
Shares To Calculate EPS Diluted23.7M24.3M29.0M29.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.74-$0.78-$0.66-$0.71
 
 
 
 
 
EPS Diluted-$0.74-$0.78-$0.66-$0.71
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account